Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Gardenia latifolia extract is a botanical preparation derived from the leaves, bark, or fruit of the Gardenia latifolia plant (family Rubiaceae), commonly known as Indian boxwood or Ceylon boxwood. Traditionally used in South Asian medicine for ailments such as snake bites, skin diseases, stomach pain, dental caries, and fevers in livestock[2][3], this plant has been studied for its diverse pharmacological properties. Phytochemical analyses reveal that extracts (especially methanol and hydroalcoholic) are rich in bioactive compounds including flavonoids, phenols, saponins, terpenoids, tannins and alkaloids[2][5][6]. The major chemical constituents identified include pyrrolizine derivatives and other secondary metabolites[5]. Mechanistically: - The ethanol and hydroalcoholic extracts have demonstrated analgesic (pain-relieving), antipyretic (fever-reducing), anti-inflammatory effects comparable to standard drugs like paracetamol[1][3]. - They exhibit significant antioxidant activity via free radical scavenging assays[1][3][5]. - Antidiabetic activity is evidenced by α-amylase enzyme inhibition in vitro and improved glucose tolerance/insulin sensitivity in animal models of type 2 diabetes mellitus; efficacy was similar to metformin at higher doses[1][4]. - Antimicrobial effects against various pathogens have also been reported for different solvent fractions of the extract[1][2]. The mechanism of action appears to involve inhibition of prostaglandin synthesis (for analgesic/antipyretic effect)[1], reduction of oxidative stress through antioxidant pathways[3], modulation of carbohydrate metabolism enzymes such as α-amylase (antidiabetic effect)[1], enhancement of insulin sensitivity/glucose uptake pathways [4], membrane stabilization [1] and direct antimicrobial actions.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on gardenia latifolia extract.